drugset / Trial / NCT05836740

Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke

NCT05836740

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study was to evaluate the efficacy and safety of Minocycline versus placebo in the treatment of patients with moderate to severe acute ischemic stroke.

Timeline

Start
2023-05-19
Primary completion
2024-05-20
Completion
2024-08-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minocycline Small molecule 100 mg Oral

Indications